Advertisement
Screener

PFIZER INC (PFE) Other Comprehensive Income (Loss), Tax

2.8 / 5 stars · 68/120 Roast Me

PFIZER INC Other Comprehensive Income (Loss), Tax

PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Tax of $53.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeLossTax · last filed 2026-08-04

  • PFIZER INC other comprehensive income (loss), tax for the quarter ending 2026-06-28 was $53.00M.
  • PFIZER INC other comprehensive income (loss), tax for the quarter ending 2026-03-29 was $81.00M.
  • PFIZER INC other comprehensive income (loss), tax for the quarter ending 2025-12-31 was $6.00M, a 98.08% decline year-over-year.
  • PFIZER INC other comprehensive income (loss), tax for the quarter ending 2025-09-28 was $45.00M.
  • PFIZER INC other comprehensive income (loss), tax for fiscal 2025 was -$486.00M, a 310.39% decline from fiscal 2024.
  • PFIZER INC other comprehensive income (loss), tax for fiscal 2024 was $231.00M.
  • PFIZER INC other comprehensive income (loss), tax for fiscal 2023 was -$85.00M.
  • PFIZER INC other comprehensive income (loss), tax for fiscal 2022 was -$187.00M, a 363.38% decline from fiscal 2021.
Period endOther Comprehensive Income (Loss), Tax 3 monthOther Comprehensive Income (Loss), Tax 3 month as first filedOther Comprehensive Income (Loss), Tax 6 monthOther Comprehensive Income (Loss), Tax 6 month as first filedOther Comprehensive Income (Loss), Tax 9 monthOther Comprehensive Income (Loss), Tax 9 month as first filedOther Comprehensive Income (Loss), Tax 12 monthOther Comprehensive Income (Loss), Tax 12 month as first filed
2026-06-28$53.00M
10-Q · filed 2026-08-04
$134.00M
10-Q · filed 2026-08-04
$140.00M
derived: sum of 3 quarters · filed 2026-08-04
$185.00M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-29$81.00M
10-Q · filed 2026-05-05
$87.00M
derived: sum of 2 quarters · filed 2026-05-05
$132.00M
derived: sum of 3 quarters · filed 2026-05-05
-$215.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$51.00M
derived: sum of 2 quarters · filed 2026-02-26
-$296.00M
derived: sum of 3 quarters · filed 2026-08-04
-$486.00M
10-K · filed 2026-02-26
2025-09-28$45.00M
10-Q · filed 2025-11-04
-$302.00M
derived: sum of 2 quarters · filed 2026-08-04
-$492.00M
10-Q · filed 2025-11-04
-$181.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-29-$347.00M
10-Q · filed 2026-08-04
-$538.00M
10-Q · filed 2026-08-04
-$226.00M
derived: sum of 3 quarters · filed 2026-08-04
-$383.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-30-$191.00M
10-Q · filed 2026-05-05
$121.00M
derived: sum of 2 quarters · filed 2026-05-05
-$36.00M
derived: sum of 3 quarters · filed 2026-05-05
-$14.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$312.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$155.00M
derived: sum of 2 quarters · filed 2026-02-26
$177.00M
derived: sum of 3 quarters · filed 2026-02-26
$231.00M
10-K · filed 2026-02-26
2024-09-29-$157.00M
10-Q · filed 2025-11-04
-$135.00M
derived: sum of 2 quarters · filed 2025-11-04
-$81.00M
10-Q · filed 2025-11-04
-$150.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$22.00M
10-Q · filed 2025-08-05
$76.00M
10-Q · filed 2025-08-05
$7.00M
derived: sum of 3 quarters · filed 2026-02-26
$43.00M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$53.00M
10-Q · filed 2025-05-05
-$15.00M
derived: sum of 2 quarters · filed 2026-02-26
$21.00M
derived: sum of 3 quarters · filed 2026-02-26
$30.00M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$68.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$32.00M
derived: sum of 2 quarters · filed 2026-02-26
-$23.00M
derived: sum of 3 quarters · filed 2026-02-26
-$85.00M
10-K · filed 2026-02-26
2023-10-01$36.00M
10-Q · filed 2024-11-04
$45.00M
derived: sum of 2 quarters · filed 2024-11-04
-$17.00M
10-Q · filed 2024-11-04
-$56.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-07-02$9.00M
10-Q · filed 2024-08-05
-$53.00M
10-Q · filed 2024-08-05
-$92.00M
derived: sum of 3 quarters · filed 2025-02-27
-$125.00M
derived: sum of 4 quarters · filed 2025-02-27
2023-04-02-$63.00M
10-Q · filed 2024-05-08
-$101.00M
derived: sum of 2 quarters · filed 2025-02-27
-$134.00M
derived: sum of 3 quarters · filed 2025-02-27
-$189.00M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$38.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$71.00M
derived: sum of 2 quarters · filed 2025-02-27
-$126.00M
derived: sum of 3 quarters · filed 2025-02-27
-$187.00M
10-K · filed 2025-02-27
2022-10-02-$33.00M
10-Q · filed 2023-11-08
-$88.00M
derived: sum of 2 quarters · filed 2023-11-08
-$149.00M
10-Q · filed 2023-11-08
-$33.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-07-03-$55.00M
10-Q · filed 2023-08-09
-$115.00M
10-Q · filed 2023-08-09
$0.00
derived: sum of 3 quarters · filed 2024-02-22
-$65.00M
derived: sum of 4 quarters · filed 2024-02-22
2022-04-03-$60.00M
10-Q · filed 2023-05-10
$55.00M
derived: sum of 2 quarters · filed 2024-02-22
-$10.00M
derived: sum of 3 quarters · filed 2024-02-22
-$73.00M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$115.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$50.00M
derived: sum of 2 quarters · filed 2024-02-22
-$13.00M
derived: sum of 3 quarters · filed 2024-02-22
$71.00M
10-K · filed 2024-02-22
2021-10-03-$65.00M
10-Q · filed 2022-11-09
-$128.00M
derived: sum of 2 quarters · filed 2022-11-09
-$44.00M
10-Q · filed 2022-11-09
$40.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-07-04-$63.00M
10-Q · filed 2022-08-10
$21.00M
10-Q · filed 2022-08-10
$105.00M
derived: sum of 3 quarters · filed 2023-02-23
$86.00M
derived: sum of 4 quarters · filed 2023-02-23
2021-04-04$84.00M
10-Q · filed 2022-05-11
$168.00M
derived: sum of 2 quarters · filed 2023-02-23
$149.00M
derived: sum of 3 quarters · filed 2023-02-23
$236.00M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$84.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$65.00M
derived: sum of 2 quarters · filed 2023-02-23
$152.00M
derived: sum of 3 quarters · filed 2023-02-23
-$227.00M
10-K · filed 2023-02-23
-$349.00M
10-K · filed 2021-02-25
2020-09-27-$19.00M
10-Q · filed 2021-11-12
-$262.00M
10-Q · filed 2020-11-05
$68.00M
derived: sum of 2 quarters · filed 2021-11-12
-$311.00M
10-Q · filed 2021-11-12
-$527.00M
10-Q · filed 2020-11-05
-$184.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-28$87.00M
10-Q · filed 2021-08-12
$113.00M
10-Q · filed 2020-08-06
-$293.00M
10-Q · filed 2021-08-12
-$265.00M
10-Q · filed 2020-08-06
-$165.00M
derived: sum of 3 quarters · filed 2022-02-24
-$81.00M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-29-$380.00M
10-Q · filed 2021-05-13
-$377.00M
10-Q · filed 2020-05-07
-$252.00M
derived: sum of 2 quarters · filed 2022-02-24
-$168.00M
derived: sum of 3 quarters · filed 2022-02-24
-$227.00M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$128.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$212.00M
derived: sum of 2 quarters · filed 2022-02-24
$153.00M
derived: sum of 3 quarters · filed 2022-02-24
$178.00M
10-K · filed 2022-02-24
$115.00M
10-K · filed 2020-02-27
2019-09-29$84.00M
10-Q · filed 2020-11-05
$25.00M
derived: sum of 2 quarters · filed 2020-11-05
$50.00M
10-Q · filed 2020-11-05
-$99.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$59.00M
10-Q · filed 2020-08-06
-$34.00M
10-Q · filed 2020-08-06
-$183.00M
derived: sum of 3 quarters · filed 2021-02-25
-$121.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$25.00M
10-Q · filed 2020-05-07
-$124.00M
derived: sum of 2 quarters · filed 2021-02-25
-$62.00M
derived: sum of 3 quarters · filed 2021-02-25
$111.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$149.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$87.00M
derived: sum of 2 quarters · filed 2021-02-25
$86.00M
derived: sum of 3 quarters · filed 2021-02-25
$518.00M
10-K · filed 2021-02-25
2018-09-30$62.00M
10-Q · filed 2019-11-07
$235.00M
derived: sum of 2 quarters · filed 2019-11-07
$667.00M
10-Q · filed 2019-11-07
$623.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-07-01$173.00M
10-Q · filed 2019-08-08
$605.00M
10-Q · filed 2019-08-08
$561.00M
derived: sum of 3 quarters · filed 2020-02-27
$481.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-04-01$432.00M
10-Q · filed 2019-05-09
$388.00M
derived: sum of 2 quarters · filed 2020-02-27
$308.00M
derived: sum of 3 quarters · filed 2020-02-27
$145.00M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31-$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
-$124.00M
derived: sum of 2 quarters · filed 2020-02-27
-$287.00M
derived: sum of 3 quarters · filed 2020-02-27
-$262.00M
10-K · filed 2020-02-27
2017-10-01-$80.00M
10-Q · filed 2018-11-08
-$243.00M
derived: sum of 2 quarters · filed 2018-11-08
-$218.00M
10-Q · filed 2018-11-08
-$503.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-07-02-$163.00M
10-Q · filed 2018-08-09
-$138.00M
10-Q · filed 2018-08-09
-$423.00M
derived: sum of 3 quarters · filed 2019-02-28
-$307.00M
derived: sum of 4 quarters · filed 2019-02-28
2017-04-02$25.00M
10-Q · filed 2018-05-10
-$260.00M
derived: sum of 2 quarters · filed 2019-02-28
-$144.00M
derived: sum of 3 quarters · filed 2019-02-28
-$108.00M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$285.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$169.00M
derived: sum of 2 quarters · filed 2019-02-28
-$133.00M
derived: sum of 3 quarters · filed 2019-02-28
-$174.00M
10-K · filed 2019-02-28
2016-10-02$116.00M
10-Q · filed 2017-11-09
$152.00M
derived: sum of 2 quarters · filed 2017-11-09
$111.00M
10-Q · filed 2017-11-09
$372.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-07-03$36.00M
10-Q · filed 2017-08-10
-$5.00M
10-Q · filed 2017-08-10
$256.00M
derived: sum of 3 quarters · filed 2018-02-22
$191.00M
derived: sum of 4 quarters · filed 2018-02-22
2016-04-03-$41.00M
10-Q · filed 2017-05-11
$220.00M
derived: sum of 2 quarters · filed 2018-02-22
$155.00M
derived: sum of 3 quarters · filed 2018-02-22
$383.00M
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$261.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$196.00M
derived: sum of 2 quarters · filed 2018-02-22
$424.00M
derived: sum of 3 quarters · filed 2018-02-22
$528.00M
10-K · filed 2018-02-22
2015-09-27-$65.00M
10-Q · filed 2016-11-10
$163.00M
derived: sum of 2 quarters · filed 2016-11-10
$267.00M
10-Q · filed 2016-11-10
-$749.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-06-28$228.00M
10-Q · filed 2016-08-11
$332.00M
10-Q · filed 2016-08-11
-$684.00M
derived: sum of 3 quarters · filed 2017-02-23
-$601.00M
derived: sum of 4 quarters · filed 2017-02-23
2015-03-29$105.00M
10-Q · filed 2016-05-12
-$912.00M
derived: sum of 2 quarters · filed 2017-02-23
-$829.00M
derived: sum of 3 quarters · filed 2017-02-23
-$824.00M
derived: sum of 4 quarters · filed 2017-02-23
2014-12-31-$1.02B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-$934.00M
derived: sum of 2 quarters · filed 2017-02-23
-$929.00M
derived: sum of 3 quarters · filed 2017-02-23
-$946.00M
10-K · filed 2017-02-23
2014-09-28$83.00M
10-Q · filed 2015-11-05
$88.00M
derived: sum of 2 quarters · filed 2015-11-05
$71.00M
10-Q · filed 2015-11-05
$1.56B
derived: sum of 4 quarters · filed 2016-02-29
2014-06-29$5.00M
10-Q · filed 2015-08-06
-$12.00M
10-Q · filed 2015-08-06
$1.47B
derived: sum of 3 quarters · filed 2016-02-29
$1.55B
derived: sum of 4 quarters · filed 2016-02-29
2014-03-30-$17.00M
10-Q · filed 2015-05-07
$1.47B
derived: sum of 2 quarters · filed 2016-02-29
$1.55B
derived: sum of 3 quarters · filed 2016-02-29
$1.74B
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$1.49B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$1.56B
derived: sum of 2 quarters · filed 2016-02-29
$1.75B
derived: sum of 3 quarters · filed 2016-02-29
$1.93B
10-K · filed 2016-02-29
2013-09-29$80.00M
10-Q · filed 2014-11-06
$267.00M
derived: sum of 2 quarters · filed 2014-11-06
$443.00M
10-Q · filed 2014-11-06
$146.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$187.00M
10-Q · filed 2014-08-07
$363.00M
10-Q · filed 2014-08-07
$66.00M
derived: sum of 3 quarters · filed 2015-02-27
$139.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$176.00M
10-Q · filed 2014-05-08
-$121.00M
derived: sum of 2 quarters · filed 2015-02-27
-$48.00M
derived: sum of 3 quarters · filed 2015-02-27
-$253.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31-$297.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
-$224.00M
derived: sum of 2 quarters · filed 2015-02-27
-$429.00M
derived: sum of 3 quarters · filed 2015-02-27
-$225.00M
10-K · filed 2015-02-27
2012-09-30$73.00M
10-Q · filed 2013-11-08
-$132.00M
derived: sum of 2 quarters · filed 2013-11-08
$72.00M
10-Q · filed 2013-11-08
-$611.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-07-01-$205.00M
10-Q · filed 2013-08-09
-$1.00M
10-Q · filed 2013-08-09
-$684.00M
derived: sum of 3 quarters · filed 2014-02-28
-$900.00M
derived: sum of 4 quarters · filed 2014-02-28
2012-04-01$204.00M
10-Q · filed 2013-05-10
-$479.00M
derived: sum of 2 quarters · filed 2014-02-28
-$695.00M
derived: sum of 3 quarters · filed 2014-02-28
-$727.00M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31-$683.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
-$899.00M
derived: sum of 2 quarters · filed 2014-02-28
-$931.00M
derived: sum of 3 quarters · filed 2014-02-28
-$959.00M
10-K · filed 2014-02-28
2011-10-02-$216.00M
10-Q · filed 2012-11-09
-$248.00M
derived: sum of 2 quarters · filed 2012-11-09
-$276.00M
10-Q · filed 2012-11-09
2011-07-03-$32.00M
10-Q · filed 2012-08-09
-$60.00M
10-Q · filed 2012-08-09
2011-04-03-$28.00M
10-Q · filed 2012-05-10
2010-12-31-$375.00M
10-K · filed 2013-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64